Skip to main content
. 2018 Jan-Feb;44(1):36–41. doi: 10.1590/S1806-37562017000000151

Table 2. Comparison between serum levels of soluble urokinase-type plasminogen activator receptor and plasma levels of fibrinogen, by GOLD stage, in patients with acute exacerbation of COPD.

Marker GOLD stage ANOVA
I or II III IV
Mean ± SD Mean ± SD Mean ± SD F p
suPAR (pg/mL)
Day 1 3,504.34 ± 542.53 5,309.23 ± 994.52 6,760.0 ± 502.81 78.232 < 0.001
Day 14 2,558.69 ± 607.38 4,084.61 ± 1,201.23 5,167.77 ± 1,054.14
Fibrinogen (mg/dL)
Day 1 443.47 ± 107.98 595.38 ± 229.98 843.33 ± 125.0 21.669 < 0.001
Day 14 337.82 ± 101.88 473.84 ± 201.31 677.77 ± 125.07

GOLD: Global Initiative for Chronic Obstructive Lung Disease; and suPAR: soluble urokinase-type plasminogen activator receptor.